ARCHIVES
VOL. 6, ISSUE 3 (2021)
Role of the antiviral drug Remdesivir in the treatment of Coronavirus disease 2019 (COVID-19)
Authors
Jitendra Patel, Pretom Chakraborty, Neelapu Laxmi Nayana, Pippalla Shruthi, Mohammed Abdul Rafe Ahmed
Abstract
The pandemic of COVID-19 (Coronavirus Disease-2019) is an highly contagious respiratory sickness due to a novel coronavirus, SARS-CoV-2. Remdesivir, different clinical trials has been done at different countries in their hospitals, when it was issued for emergency drug. Its safety profile has been evaluated in a merciful use setting for patients with COVID-19. The current therapeutic examination demonstrate clinical efficacy of remdesivir in COVID-19 patients by reducing time to clinical recovery, and hospitalization. In this regards, we srncerely analyze the recent evidence of remdesivir against COVID-19 and automize the aspects over its efcacy and safety. Based on available data, remdesivir can be noticed as a potential therapeutic drug against COVID-19. Further, randomized placebo-controlled clinical trials anticipate to validate these fndings.
Download
Pages:27-30
How to cite this article:
Jitendra Patel, Pretom Chakraborty, Neelapu Laxmi Nayana, Pippalla Shruthi, Mohammed Abdul Rafe Ahmed "Role of the antiviral drug Remdesivir in the treatment of Coronavirus disease 2019 (COVID-19) ". International Journal of Research in Pharmacy and
Pharmaceutical Sciences, Vol 6, Issue 3, 2021, Pages 27-30
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.